Yuting Wu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Traditional Chinese Medicine Analysis
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 6
- Circular RNAs in diseases 4
- FOXO transcription factor regulation 4
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 3
- Co-authors
- Xiaochun Qin (5 shared papers)Qingchun Zhao (5 shared papers)Yingshi Zhang (2 shared papers)Daiying Zuo (1 shared paper)Yingchun Zhou (8 shared papers)Honglin Xu (7 shared papers)Guoyong Zhang (7 shared papers)Guang‐Hong Chen (6 shared papers)
In The Last Decade
Yuting Wu
29 papers receiving 560 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 131
- Complementary and alternative medicine 43
- Pharmacology 45
- Molecular Biology 351
- Oncology 104
Countries citing papers authored by Yuting Wu
This map shows the geographic impact of Yuting Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting Wu more than expected).
Fields of papers citing papers by Yuting Wu
This network shows the impact of papers produced by Yuting Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting Wu. The network helps show where Yuting Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuting Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 102 | |
| 2 | 2012 | 72 | |
| 3 | 2021 | 58 | |
| 4 | 2012 | 30 | |
| 5 | 2021 | 29 | |
| 6 | 2021 | 29 | |
| 7 | 2021 | 28 | |
| 8 | 2022 | 26 | |
| 9 | 2021 | 23 | |
| 10 | 2020 | 21 | |
| 11 | 2023 | 18 | |
| 12 | 2022 | 16 | |
| 13 | 2018 | 14 | |
| 14 | 2021 | 14 | |
| 15 | 2021 | 13 | |
| 16 | 2024 | 13 | |
| 17 | 2020 | 13 | |
| 18 | 2022 | 8 | |
| 19 | 2024 | 8 | |
| 20 | 2022 | 8 |
About Yuting Wu
Yuting Wu is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology, having authored 30 papers that have together received 567 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Cancer Mechanisms and Therapy (5 papers), Ferroptosis and cancer prognosis (4 papers), Circular RNAs in diseases (4 papers), FOXO transcription factor regulation (4 papers), MicroRNA in disease regulation (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (131 citations), Complementary and alternative medicine (43 citations), Pharmacology (45 citations), Molecular Biology (351 citations) and Oncology (104 citations). Yuting Wu has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Xiaochun Qin, Qingchun Zhao, Yingshi Zhang, Daiying Zuo, Yingchun Zhou, Honglin Xu, Guoyong Zhang, Guang‐Hong Chen, Bin Liu and Lingpeng Xie. Their work appears in journals such as Frontiers in Oncology, Journal of Ethnopharmacology, Biochemical Pharmacology, Phytomedicine and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.